Fulcrum Therapeutics, Inc.
FULCBiotechnology
$3.77+0.53%As of Oct 29vs prior close
- P/E (TTM)
- –
- From 52W high
- −74.18%
- EPS (YE25)
- -$1.18
- Revenue (YE25)
- $0
- Dividend yield
- 0.00%
Nomior Score
29
Steady ProfileBottom 14% of the scored universe
Growth44
Quality54
Value43
Momentum8
Resilience44
Growth
$0revenue, YE25
YE20 $8.8MYE25 $0
Connections
Revenue to profitYE24
The operating loss was 27% of revenue, narrower by 3918 pts on a year.
Who owns it
2funds